miDiagnostics

📍 Heverlee, Belgium🗓 Founded 2015👥 37 employees💰 Last funded May 2019
Medical Devices🌐 midiagnostics.com
Website LinkedIn
miDiagnostics is developing a new generation of disposable tests that require only drops of blood and allow detection of cells, proteins, nucleic acids, and/or small molecules. Its core technology is a novel silicon-based nanofluidic processor that automatically processes the blood sample without the need of pumps or valves. There is no need for complex and costly instrumentation enabling medical decisions to be taken at the point of need or remote areas with a high level of comfort to both patients and caregivers.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2015
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Belgium
2
Frequently asked questions
Who invested in miDiagnostics?
miDiagnostics has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did miDiagnostics last raise funding?
The most recent investment in miDiagnostics recorded on gritt.io was in May 2019.
When was miDiagnostics founded?
miDiagnostics was founded in 2015.
What industry is miDiagnostics in?
miDiagnostics operates in Medical Devices. Find similar Medical Devices investors on gritt.io.
Where is miDiagnostics based?
miDiagnostics is headquartered in Heverlee, Belgium.